Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
6/2003
vol. 105 abstract:
Original paper
Photodynamic therapy with indocyanine green for choroidal neovascularization caused by age-related macular degeneration – a preliminary report
Agnieszka Kubicka-Trząska
1
,
Maria Starzycka
1
Online publish date: 2003/12/21
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction
To evaluate the usefulness of indocyanine green in the photodynamic therapy (iPDT) of choroidal neovascularization (CNV) in age-related macular degeneration (AMD). Material and methods Twelve patients with choroidal neovascularization secondary to AMD were treated with iPDT. Therapy was performed with 810 nm diode laser after intravenous injection of 25 mg solution of indocyanine green. Within 3 months follow-up two visits were performed with ICGA images evaluation, at each control. Results After therapy complete regression of the CNV was demonstrated by ICGA in 3 cases, partial regression was found in 5 patients, 3 revealed no changes and in one case the progression of the CNV was noted in spite of the treatment. Six patients presented increase in visual acuity, in 5 no changes were observed, and in one case a 2-line decrease in VA was detected by 3 months of follow-up. Conclusions Our preliminary study suggests that ICG mediated PDT can be a new and promising way, to treat neovascular AMD. keywords:
photodynamic therapy, indocyanine green, choroidal neovascularization, age-related macular degeneration |
|